Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-05-17
1978-09-19
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260112R, 2602395, 260291, 424 12, A61K 4300, G01N 3300
Patent
active
041155394
ABSTRACT:
Novel isocyanates such as, for example, blocked L-tyrosine methyl ester isocyanate, are reacted with compounds of biological, clinical interest or the like such as, for example, digoxin, to form derivatives receptive to tagging, as by radiolabeling. The tagged derivatives may then be employed to determine the presence of the compound of interest in nanomolar or even picomolar amounts by using clinical analysis techniques such as radioimmunoassay.
REFERENCES:
patent: 3843696 (1974-10-01), Wagner et al.
patent: 3867366 (1975-02-01), Rubenstein et al.
patent: 3878187 (1975-04-01), Schneider et al.
patent: 3888866 (1975-06-01), Leute et al.
patent: 3953431 (1976-04-01), Rutner et al.
patent: 3996344 (1976-12-01), Gross
Eisenhardt, Jr. William Anthony
Hedaya Eddie
Theodoropulos Spyros
Moran William Raymond
Nucker Christine M.
Padgett Benjamin R.
Union Carbide Corporation
LandOfFree
Analytical or clinical derivatives, tagged derivatives and metho does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analytical or clinical derivatives, tagged derivatives and metho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analytical or clinical derivatives, tagged derivatives and metho will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2120012